AKT1 and cancer: As depicted in Table 3, the enriched pathways predominantly included cancer, metabolic, lipid and atherosclerosis, as well as phosphoinositide-3-kinase-protein kinase B (PI3K-Akt), and mitogen‐activated protein kinase (MAPK) signaling pathways.